Medicine
CN β USProduct Images
AI Analysis
π Medicine (Pharmaceutical Products)
π HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional-Level Clearance Strategy
π I. Product Definition & Classification: Do You Really Understand βMedicineβ?
Medicine, in the context of international trade and customs classification, refers to pharmaceutical products intended for therapeutic, prophylactic, or diagnostic purposes. It is a highly regulated category with strict quality standards and specific HS Code classifications based on the form, ingredients, and intended use.
In international trade, medicine is primarily divided into two main categories:
- Prepared Pharmaceutical Products (HS Chapter 30): These are finished drugs, including tablets, capsules, liquids, injectables, creams, and ointments, ready for consumer use. They are classified under Heading 30.04 or 30.06.
- Active Pharmaceutical Ingredients (APIs) & Bulk Drugs: These are the raw chemical substances used to manufacture medicines. They are classified under Heading 29 (e.g., organic chemicals) or Chapter 30 if specifically identified as products of heading 30.01 or 30.02.
β οΈ Key Distinction Points: - Finished Dosage Forms (tablets, capsules, etc.) β HS Code 3004 / 3006 - Bulk Chemicals/APIs (not in measurable doses or retail packaging) β HS Code 29xxxx (specific subheading based on chemical structure) - Vaccines, Blood Products, Hormones β HS Code 3002 - Medical Kits/First Aid Sets β HS Code 3006
π¦ II. HS Code Classification Details (2026 Latest Tariff Authority Reference)
| HS Code | Product Description | Application Scenario | Dosage Form/Retail Packaging |
|---|---|---|---|
3004.90.55.00 |
Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, in measured doses or put up in retail packaging | Most common OTC and prescription drugs (tablets, capsules, syrups) | β Yes |
3004.10.00.00 |
Medicaments containing penicillins or derivatives thereof, with or without other substances | Antibiotics (Penicillin-based) | β Yes |
3004.20.00.00 |
Medicaments containing streptomycins or their derivatives | Antibiotics (Streptomycin-based) | β Yes |
3004.31.00.00 |
Medicaments containing insulin | Diabetic treatments | β Yes |
3004.32.00.00 |
Medicaments containing hormones or steroids | Hormonal therapies (e.g., cortisone, testosterone) | β Yes |
3004.90.90.00 |
Other medicaments | Miscellaneous drugs not specified above | β Yes |
3002.11.00.00 |
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic purposes | Blood products, plasma, vaccines | β Yes |
2933.39.00.00 |
Heterocyclic compounds with nitrogen heteroatoms only (e.g., some APIs) | Bulk pharmaceutical ingredients (not in dose/retail pack) | β No |
2937.11.00.00 |
Insulin and its derivatives | Bulk insulin (API form) | β No |
π Critical Reminder: - Finished drugs (in measured doses or retail packaging) must be classified under Heading 3004 or 3006. - Bulk APIs (raw chemicals) are often classified under Chapter 29 (Chemical Products), not Chapter 30, unless specifically excluded. - Vaccines and blood products are classified under Heading 3002. - Misclassification can lead to severe penalties, especially for controlled substances or high-tariff APIs.
π° III. 2026 Latest Tariff Rate Details (Including Surtaxes & Policy Add-ons)
β Applicable Country: United States (US)
β Origin: China (CN)
β Effective Date: November 10, 2025 (including subsequent imports)
π― 1. 3004.90.55.00 β General Medicaments (Most OTC & Prescription Drugs)
| Item | Content |
|---|---|
| Basic Tariff Rate | 0% (ad valorem) |
| USITC Surtax | +25% (from USITC Footnote 9903.88.01) |
| IEEPA Surtax | +10% (against Chinese/Hong Kong products, effective Nov 10, 2025) |
| Total Tariff Rate | 35% |
| Tax Calculation | CIF Value Γ 35% |
| De Minimis Exemption Available? | β No (deny_de_minimis) |
| Legal Basis Path | IEEPA:9903.01.25 β IEEPA:9903.01.24 β USITC:3004.90.55.00 β FOOTNOTE:9903.88.01 |
π Explanation: - The β25% USITC Surtaxβ stems from Section 301 tariffs under the U.S. Trade Act. - The β10% IEEPA Surtaxβ is an additional duty against Chinese-origin goods. - Total 35% is a high tariff rate, requiring advance planning!
π― 2. 3004.10.00.00 β Penicillin-Based Medicaments
| Item | Content |
|---|---|
| Basic Tariff Rate | 0% |
| USITC Surtax | +25% |
| IEEPA Surtax | +10% |
| Total Tariff Rate | 35% |
| Tax Calculation | CIF Γ 35% |
| De Minimis Exemption Available? | β No |
| Legal Basis Path | IEEPA:9903.01.25 β IEEPA:9903.01.24 β USITC:3004.10.00.00 β FOOTNOTE:9903.88.01 |
π Note: - Same tax structure as general medicaments. - Applies to all penicillin-based drugs, regardless of dosage form.
π― 3. 3002.11.00.00 β Human Blood / Blood Products
| Item | Content |
|---|---|
| Basic Tariff Rate | 0% |
| USITC Surtax | +25% |
| IEEPA Surtax | +10% |
| Total Tariff Rate | 35% |
| Tax Calculation | CIF Γ 35% |
| De Minimis Exemption Available? | β No |
π Note: - Blood products and vaccines are subject to the same surtaxes. - These goods require FDA approval and import licenses.
π οΈ IV. Customs Clearance Practical Advice (Real-World Pitfall Avoidance Guide)
β 1. Documentation Checklist (None Can Be Missing)
| Document | Required | Description |
|---|---|---|
| β Product Specification Sheet | βοΈ | Includes dosage, active ingredients, concentration, route of administration |
| β Certificate of Analysis (CoA) | βοΈ | Verifies purity, potency, and quality standards |
| β FDA Import Prior Notice | βοΈ | Mandatory for drugs entering the U.S. |
| β FDA Drug Listing & Registration | βοΈ | Establishes facility and product registration |
| β Commercial Invoice | βοΈ | Clearly states βPharmaceutical Product, [HS Code]β |
| β Certificate of Origin (CO) | βοΈ | If non-Chinese origin, may qualify for reduced tariffs |
| β Packing List | βοΈ | Details inner/outer packaging, batch numbers, expiration dates |
| β FDA Prior Notice Confirmation | βοΈ | Must be submitted before arrival |
β 2. Declaration Tips (Key Mantra)
π₯ βFinished drugs go to 3004, APIs go to 29, vaccines to 3002, and misclassification brings fines!β
| Scenario | Correct Declaration Method | Incorrect Practice |
|---|---|---|
| Finished Tablets/Capsules | 3004.90.55.00 |
Misdeclare as βChemicalsβ β 35% + penalties |
| Bulk API (Raw Powder) | 29xxxx (e.g., 2933.39.00) |
Misdeclare as βFinished Drugβ β 35% + FDA hold |
| Vaccines | 3002.11.00.00 |
Misdeclare as βMedicamentβ β 35% + FDA rejection |
| Medical Kits | 3006 |
Misdeclare as βDrugsβ β 35% + inspection delay |
β 3. Special Case Handling
| Scenario | Handling Advice |
|---|---|
| OEM/Private Label Drugs | Provide contract, manufacturing authorization, and FDA registration proof |
| Controlled Substances | Require DEA Importer Registration and Controlled Substance Import Permit |
| Biologics (Vaccines, Insulin) | Require Biologics License Application (BLA) and FDA Prior Notice |
| Drugs for Personal Use | May qualify for de minimis if < $800, but not for commercial shipments |
| Expired or Recalled Drugs | Prohibited from import; may result in seizure and fines |
π V. Global Major Market Clearance Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Tariff | Certification Requirements | Remarks |
|---|---|---|---|---|
| πΊπΈ United States | 3004.90.55.00 |
35% (China origin) | FDA + Prior Notice | High regulation; 35% tariff |
| π¨π³ China | 3004.90.55.00 |
0% | NMPA (formerly CFDA) | No surtaxes |
| πͺπΊ European Union | 3004 |
0% (if CE/GMP) | EMA + GMP + CEP | Free trade within EU |
| π¦πΊ Australia | 3004 |
5% | TGA | No surtaxes |
| π―π΅ Japan | 3004 |
0% | PMDA | No surtaxes |
π Conclusion: - The U.S. is the only major market imposing high surtaxes on Chinese pharmaceutical products. - China-origin drugs face 35% tariffs in the U.S., making pre-clearance planning essential. - EU, Japan, Australia have lower or zero tariffs but require strict GMP/EMA/TGA approvals.
π VI. Common Errors & Pitfall Avoidance (Lessons from Real Cases)
β Error 1: Declaring finished tablets as βChemicalsβ (Chapter 29)
π Consequence: 35% tariff + FDA rejection + fines
β Error 2: Failing to submit FDA Prior Notice before arrival
π Consequence: Shipment held at port; potential return or destruction
β Error 3: Misclassifying bulk APIs as finished drugs
π Consequence: Unnecessary 35% tariff + quality inspection delays
β Error 4: Using vague descriptions like βMedicineβ or βDrugβ without HS Code
π Consequence: Customs may misclassify, leading to penalties and delays
β Correct Practice:
βParacetamol Tablets, 500mg, 100 tablets/blister, for oral use, FDA-approved, HS Code 3004.90.55.00β
π― VII. Conclusion: Professional Declaration Saves Time, Money, and Risk
π― Remember the Mantra:
πΉ βFinished drugs β 3004, APIs β 29, vaccines β 3002, and misclassification brings fines!β
πΉ βHS Code determines tariff, tariff determines cost, and correct declaration saves thousands!β
π Pro Tip:
If your pharmaceutical products originate from Vietnam, India, Malaysia, or Thailand, you may qualify for IEEPA exemptions, reducing the tariff to 0%~5%.
Recommendation: Apply for an Advance Ruling from U.S. Customs and Border Protection (CBP) to avoid clearance risks.
π£ Immediate Action:
π Contact a licensed customs broker + Provide FDA documentation + Apply for HS Code Advance Ruling
π Ensure your pharmaceutical products clear customs smoothly, efficiently, and cost-effectively!
β¨ Professional Clearance Starts with Accurate Classification!
πΌ Every cent of cost deserves precise calculation!
Customer Reviews
About HS Code Classification
The Harmonized System (HS) is an internationally standardized nomenclature developed by the World Customs Organization (WCO) to classify traded products. Over 200 countries use the HS system as the basis for customs tariffs, trade statistics, and import/export regulations.
Each HS code follows a hierarchical structure:
- Chapter (2 digits) β Broad category of goods (e.g., Chapter 84: Machinery and Mechanical Appliances)
- Heading (4 digits) β More specific grouping within the chapter
- Subheading (6 digits) β Internationally standardized breakdown, used by all WCO member countries
- National subdivisions (8-10 digits) β Country-specific extensions for further classification, such as US HTSUS 10-digit codes
Correct HS code classification is essential for smooth customs clearance, accurate duty payment, and compliance with trade regulations. Misclassification can lead to customs delays, overpayment of duties, or penalties.
When importing from CN to US, the applicable tariff rates may include:
- Most-Favored-Nation (MFN) rate β The standard duty rate applied to WTO members
- General rate β Applied to countries without trade agreements
- Trade remedy duties β Additional tariffs such as Section 301 (anti-dumping), Section 232 (national security), or countervailing duties
The information provided on this page is for reference purposes only. For official classification, please consult with your local customs authority or a licensed customs broker.